These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 28351314)
1. Inactivation of parkin by promoter methylation correlated with lymph node metastasis and genomic instability in nasopharyngeal carcinoma. Ni H; Zhou Z; Jiang B; Yuan X; Cao X; Huang G; Li Y Tumour Biol; 2017 Mar; 39(3):1010428317695025. PubMed ID: 28351314 [TBL] [Abstract][Full Text] [Related]
2. [Inactivation of PMS2 gene by promoter methylation in nasopharyngeal carcinoma]. Ni HF; Jiang B; Zhou Z; Li Y; Yuan XY; Cao XL; Huang GW Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):812-817. PubMed ID: 27998438 [No Abstract] [Full Text] [Related]
3. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma. Zhang Z; Sun D; Van do N; Tang A; Hu L; Huang G Int J Cancer; 2007 Jan; 120(1):32-8. PubMed ID: 17013896 [TBL] [Abstract][Full Text] [Related]
4. Effects of DACT1 methylation status on invasion and metastasis of nasopharyngeal carcinoma. Yang JH; Lin LK; Zhang S Biol Res; 2019 Jun; 52(1):31. PubMed ID: 31182157 [TBL] [Abstract][Full Text] [Related]
5. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma. Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391 [TBL] [Abstract][Full Text] [Related]
6. Inactivation of MSH3 by promoter methylation correlates with primary tumor stage in nasopharyngeal carcinoma. Ni H; Jiang B; Zhou Z; Yuan X; Cao X; Huang G; Li Y Int J Mol Med; 2017 Sep; 40(3):673-678. PubMed ID: 28656302 [TBL] [Abstract][Full Text] [Related]
7. Promoter hypermethylation along with LOH, but not mutation, contributes to inactivation of DLC-1 in nasopharyngeal carcinoma. Feng X; Ren C; Zhou W; Liu W; Zeng L; Li G; Wang L; Li M; Zhu B; Yao K; Jiang X Mol Carcinog; 2014 Nov; 53(11):858-70. PubMed ID: 23908159 [TBL] [Abstract][Full Text] [Related]
8. Inactivation of 14-3-3 sigma by promoter methylation correlates with metastasis in nasopharyngeal carcinoma. Yi B; Tan SX; Tang CE; Huang WG; Cheng AL; Li C; Zhang PF; Li MY; Li JL; Yi H; Peng F; Chen ZC; Xiao ZQ J Cell Biochem; 2009 Apr; 106(5):858-66. PubMed ID: 19160382 [TBL] [Abstract][Full Text] [Related]
9. [Aberrant promoter hypermethylation of CHFR in nasopharyngeal carcinoma]. Huang T; Du C; Yu N; Xiao X; Zhou X; Wang S; Huang G; Zhang Z Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Aug; 25(16):746-50. PubMed ID: 22070084 [TBL] [Abstract][Full Text] [Related]
10. GALC gene is downregulated by promoter hypermethylation in Epstein-Barr virus-associated nasopharyngeal carcinoma. Zhao Y; Guo Y; Wang Z; Xiao Z; Li R; Luo A; Wu C; Jing Z; Sun N; Chen X; Du H; Zeng Y Oncol Rep; 2015 Sep; 34(3):1369-78. PubMed ID: 26178533 [TBL] [Abstract][Full Text] [Related]
11. Frequent epigenetic inactivation of Myocardin in human nasopharyngeal carcinoma. Chen F; Mo Y; Ding H; Xiao X; Wang SY; Huang G; Zhang Z; Wang SZ Head Neck; 2011 Jan; 33(1):54-9. PubMed ID: 20848417 [TBL] [Abstract][Full Text] [Related]
12. FEZF2, a novel 3p14 tumor suppressor gene, represses oncogene EZH2 and MDM2 expression and is frequently methylated in nasopharyngeal carcinoma. Shu XS; Li L; Ji M; Cheng Y; Ying J; Fan Y; Zhong L; Liu X; Tsao SW; Chan AT; Tao Q Carcinogenesis; 2013 Sep; 34(9):1984-93. PubMed ID: 23677067 [TBL] [Abstract][Full Text] [Related]
13. [Detection of gene promoter methylation and mRNA, protein expression levels of E-cadherin in nasopharyngeal carcinoma]. Li Z; Lin SX; Liang YJ Zhonghua Bing Li Xue Za Zhi; 2003 Feb; 32(1):25-30. PubMed ID: 12760799 [TBL] [Abstract][Full Text] [Related]
14. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma. Wang T; Liu H; Chen Y; Liu W; Yu J; Wu G J Exp Clin Cancer Res; 2009 Dec; 28(1):160. PubMed ID: 20042089 [TBL] [Abstract][Full Text] [Related]
15. [The expression of clock gene CLOCK and its clinical significance in nasopharyngeal carcinoma]. Li XM; Li YY; Zhao CF; Liu LN; He QY; Jiang JQ; Chen Y; Yang MH; Tang YX; Li YX; Jin F Zhonghua Zhong Liu Za Zhi; 2021 Dec; 43(12):1255-1263. PubMed ID: 34915633 [No Abstract] [Full Text] [Related]
16. Molecular alterations of the WWOX gene in nasopharyngeal carcinoma. Yang Z; Lan H; Chen X; Li P; Li S; Mo W; Tang A Neoplasma; 2014; 61(2):170-6. PubMed ID: 24299313 [TBL] [Abstract][Full Text] [Related]
17. Aberrant CpG island methylation of PTEN is an early event in nasopharyngeal carcinoma and a potential diagnostic biomarker. Li J; Gong P; Lyu X; Yao K; Li X; Peng H Oncol Rep; 2014 May; 31(5):2206-12. PubMed ID: 24604064 [TBL] [Abstract][Full Text] [Related]
18. TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma. Wang S; Xiao X; Zhou X; Huang T; Du C; Yu N; Mo Y; Lin L; Zhang J; Ma N; Murata M; Huang G; Zhang Z BMC Cancer; 2010 Nov; 10():617. PubMed ID: 21062455 [TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of high-in-normal 1 gene in primary nasopharyngeal carcinoma. Wong TS; Kwong DL; Sham JS; Tsao SW; Wei WI; Kwong YL; Yuen AP Clin Cancer Res; 2003 Aug; 9(8):3042-6. PubMed ID: 12912954 [TBL] [Abstract][Full Text] [Related]
20. Subtelomeric demethylation deregulated hTERT expression, telomerase activity, and telomere length in four nasopharyngeal carcinoma cell lines. Zhang ZX; Wang Y; Tao ZZ; Chen SM; Xiao BK; Zhou T Cancer Biother Radiopharm; 2014 Sep; 29(7):289-94. PubMed ID: 25153197 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]